Overview
- Editors:
-
-
Vivek Agrahari
-
CONRAD / Eastern Virginia Medical School, Arlington, USA
-
Anthony Kim
-
Department of Neurosurgery and Pharmacology, University of Maryland School of Medicine, Baltimore, USA
-
Vibhuti Agrahari
-
Department of Pharmaceutical Sciences, College of Pharmacy, University of Oklahoma Health Science Center, Oklahoma City, USA
- Includes cutting-edge methods and protocols
- Provides step-by-step detail essential for reproducible results
- Contains key notes and implementation advice from the experts
Access this book
Other ways to access
About this book
This volume provides a guide on nanoformulations and other drug delivery approaches for both academic and industry scientists. The chapters in this book cover diverse topics and techniques in nanoparticle drug delivery, gene therapy, neurosurgical brain implant, exosomes, MRI-guided focused ultrasound (MRgFUS), and advanced preclinical glioblastoma multiforme animal models. Some chapters discuss state-of-the-art and innovative nanomedicines for glioblastoma, surface-modified nanoparticle drug carriers for brain cancer treatment, focused ultrasound (FUS)-mediated blood-brain barrier disruption for enhanced drug delivery to brain tumors; gene therapy delivery approaches to treat brain cancer, and a liposome-template hydrogel nanoparticles (LHNPs) as a powerful CRISPR/Cas9 delivery vehicle. In the Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory.
Cutting-edge and thorough, Nanotherapy for Brain Tumor Drug Delivery is a valuable resource for the scientific community working on this important therapeutic field, and will help fast-track the clinical translation of revolutionary nanotechnologies for treating brain tumors.
Similar content being viewed by others
Table of contents (12 protocols)
-
Front Matter
Pages i-xiii
-
- Valeria Sgarbi, Jason T. Duskey, Ilaria Ottonelli, Federica Da Ros, Natalia Oddone, Maria Angela Vandelli et al.
Pages 1-61
-
- Amr Hefnawy, Ibrahim M. El-Sherbiny
Pages 63-78
-
- Paula Schiapparelli, Montserrat Lara-Velazquez, Rawan Al-kharboosh, Hao Su, Honggang Cui, Alfredo Quinones-Hinojosa
Pages 79-108
-
- Mark Bell, Christine Pujol Rooks, Vibhuti Agrahari
Pages 109-126
-
- Aniket S. Wadajkar, Nina P. Connolly, Christine P. Carney, Pranjali P. Kanvinde, Jeffrey A. Winkles, Graeme F. Woodworth et al.
Pages 127-144
-
- Mohd Imran, Awais Ahmed Abrar Ahmed, Babak Kateb, Ajeet Kaushik
Pages 145-178
-
- Karina Negron, Namir Khalasawi, Jung Soo Suk
Pages 179-204
-
- Pavlos Anastasiadis, Jeffrey A. Winkles, Anthony J. Kim, Graeme F. Woodworth
Pages 205-223
-
- Joshua Casaos, Noah Gorelick, Betty Tyler
Pages 225-244
-
- Zeming Chen, Ann T. Chen, Jiangbing Zhou
Pages 245-257
-
- Yen Nguyen, Sandeep Kaur, Hae Shim, Vaibhav Mundra, Venkatareddy Nadithe
Pages 259-279
-
- João Basso, José Sereno, Ana Fortuna, Miguel Castelo-Branco, Carla Vitorino
Pages 281-296
-
Back Matter
Pages 297-298
Editors and Affiliations
-
CONRAD / Eastern Virginia Medical School, Arlington, USA
Vivek Agrahari
-
Department of Neurosurgery and Pharmacology, University of Maryland School of Medicine, Baltimore, USA
Anthony Kim
-
Department of Pharmaceutical Sciences, College of Pharmacy, University of Oklahoma Health Science Center, Oklahoma City, USA
Vibhuti Agrahari